Zinc for Loss of Appetite

Loss of appetite is one of the classic signs of zinc deficiency, and one of the few nutritional causes that resolves quickly once corrected.

Zinc deficiency impairs taste - producing hypogeusia or distorted taste - and reduced enjoyment of food follows directly. Anorexia is a recognised feature of deficiency states, and supplementation improves appetite and weight gain in deficient children in low-income settings, in patients with liver disease and in some anorexia nervosa protocols where zinc has been trialled as an adjunct. The caveat is that this is correction, not stimulation. In people with adequate zinc status, supplementation does not increase appetite, and taken on an empty stomach it more often causes nausea and reduces the desire to eat. Appetite loss has many causes - infection, depression, medication, malignancy - and zinc addresses only one.

Appetite is driven by hypothalamic circuits responding to ghrelin, leptin and nutrient signals, and heavily modulated by the sensory experience of eating. Taste and smell shape food reward, so anything that dulls them reduces intake.

Zinc is required for gustin, or carbonic anhydrase VI, a salivary protein involved in taste bud development and maintenance, and taste receptor cells turn over rapidly and depend on adequate zinc for renewal. Deficiency therefore blunts taste within weeks. Zinc also influences hypothalamic NPY signalling and has been linked to ghrelin regulation in animal models. Because zinc is poorly stored, intake shortfalls show up relatively quickly, and the resulting appetite loss further reduces zinc intake - a self-reinforcing loop that supplementation interrupts.

Take it with food, and give it a few weeks.

There are currently no studies linked to this pairing in our library, so no study list is shown.

Anorexia and taste disturbance are established clinical features of zinc deficiency, described since the original human deficiency syndromes were characterised. Supplementation trials in deficient children show improved appetite, intake and growth, and zinc has improved taste acuity in patients with cirrhosis and in some post-viral taste disturbance. Evidence outside deficiency is poor. Trials are mostly small, conducted in malnourished or clinically ill populations, and appetite is often a secondary or subjectively rated endpoint. Serum zinc is an unreliable marker of body stores and falls during inflammation, complicating diagnosis. No evidence supports zinc as an appetite stimulant in replete people.

Zinc up to 40 mg daily is safe for most adults. Nausea, vomiting and metallic taste are the main side effects and are largely avoided by taking it with a meal.

Chronic intake above 40 mg daily blocks copper absorption, causing anaemia and potentially irreversible myeloneuropathy. In severe undernutrition, reintroducing food carries a risk of refeeding syndrome and requires medical supervision. Many medications - including metformin, SSRIs, opioids and chemotherapy - suppress appetite, and reviewing them is often more productive than supplementing.

Other causes of appetite loss usually matter more than zinc status.

No studies are currently linked to this pairing, so no reference list is available. This section will populate as evidence is added to the library.